These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051 [No Abstract] [Full Text] [Related]
33. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. Bartlett JA; Fath MJ; Demasi R; Hermes A; Quinn J; Mondou E; Rousseau F AIDS; 2006 Oct; 20(16):2051-64. PubMed ID: 17053351 [TBL] [Abstract][Full Text] [Related]
34. Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts. Calmy A; Petoumenos K; Lewden C; Law M; Bocquentin F; Hesse K; Cooper D; Carr A; Bonnet F; HIV Med; 2007 Apr; 8(3):171-80. PubMed ID: 17461861 [TBL] [Abstract][Full Text] [Related]
35. FDA notifications. NRTI Emtriva receives FDA approval. AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301 [TBL] [Abstract][Full Text] [Related]
36. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection. Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083 [TBL] [Abstract][Full Text] [Related]
37. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy. Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718 [TBL] [Abstract][Full Text] [Related]
39. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients. Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023 [TBL] [Abstract][Full Text] [Related]
40. Two new NNRTIs enter the pipeline. Dalton P Proj Inf Perspect; 2008 Sep; (46):13. PubMed ID: 19048672 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]